| Jillian Byron, | |
|
1488a E 52nd St, Brooklyn, NY 11234-3208 | |
| (347) 512-4044 | |
| Not Available |
| Full Name | Jillian Byron |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1488a E 52nd St, Brooklyn, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003130915 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 207284 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jillian Byron, 1488a E 52nd St, Brooklyn, NY 11234-3208 Ph: () - | Jillian Byron, 1488a E 52nd St, Brooklyn, NY 11234-3208 Ph: (347) 512-4044 |
News Archive
In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in core symptoms of autism.
The authorization committee of the German Research Foundation (DFG) has approved funding for a collaborative research center proposed by the University of Freiburg on the topic „Control of Cell Motility in Morphogenesis, Tumor Invasion, and Metastatic Spread" starting on 1 January 2010. The Freiburg SFB 850 will receive a total of 9.4 million euros in the next four years plus a 20 percent program allowance for indirect costs. In the case of success, the SFB 850 is eligible to receive funding for up to 12 years.
Boehringer Ingelheim, a global pharmaceutical group of companies, together with its U.S. animal health business Boehringer Ingelheim Vetmedica, Inc., announced today that it has entered into an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceutical's Fort Dodge Animal Health business upon the closing of the global Pfizer-Wyeth merger, which is expected to occur early in the fourth quarter.
Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.
› Verified 2 days ago
Jonneka Ferguson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 174 E 51st St, Brooklyn, NY 11203 Phone: 718-671-2100 | |
Marlon Artito Hinds, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 120 E 57th St, Brooklyn, NY 11203 Phone: 347-957-7352 | |
Ludenie Arecy, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2505 Tilden Ave, Brooklyn, NY 11226 Phone: 718-941-4490 Fax: 718-703-1716 | |
Yvette Jubuisson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2920 Cortelyou Rd, Brooklyn, NY 11226 Phone: 718-287-4300 Fax: 718-287-4600 | |
Rodgeria Augustine, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 287 Linden Blvd, Apt D2, Brooklyn, NY 11226 Phone: 646-355-5052 | |
Elizabeth Obiamaka Obiora I, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 140 E New York Ave, 4-f, Brooklyn, NY 11225 Phone: 347-455-7507 |